摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-<(Tosyloxy)methyl>bicyclo<2.2.1>heptane | 13866-80-3

中文名称
——
中文别名
——
英文名称
1-<(Tosyloxy)methyl>bicyclo<2.2.1>heptane
英文别名
(norborn-1-yl)methyl tosylate;bicyclo<2.2.1>heptan-1-ylmethyl toluene-p-sulphonate;bicyclo[2.2.1]heptan-1-ylmethyl 4-methylbenzenesulfonate;Tosylat des 1-Hydroxymethyl-bicyclo<2.2.1>heptan;toluene-4-sulfonic acid-[1]norbornylmethyl ester;Toluol-4-sulfonsaeure-[1]norbornylmethylester;1-Bicyclo[2.2.1]heptanylmethyl 4-methylbenzenesulfonate
1-<(Tosyloxy)methyl>bicyclo<2.2.1>heptane化学式
CAS
13866-80-3
化学式
C15H20O3S
mdl
——
分子量
280.388
InChiKey
QSZLTTLESAOWFN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    405.5±14.0 °C(Predicted)
  • 密度:
    1.219±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Strained Small Ring Compounds: Bridgehead Substituted Bicyclo [2.1.1]hexanes
    摘要:
    DOI:
    10.1021/ja00903a031
  • 作为产物:
    描述:
    双环[2.2.1]庚烷-1-羧酸吡啶 、 lithium aluminium tetrahydride 作用下, 以 二氯甲烷 为溶剂, 反应 96.0h, 生成 1-<(Tosyloxy)methyl>bicyclo<2.2.1>heptane
    参考文献:
    名称:
    Synthesis of bridgehead-substituted bicyclo[2.2.1]heptanes by radical cyclization
    摘要:
    A kinetic investigation shows that the rate of cyclization (k(C)) of the (4-methylenecyclohexyl)methyl radical 3 at 25-degrees-C is 4.4 x 10(2) s-1, which is considerably slower than that (2.3 x 10(5) s-1) of the parent 5-hexenyl radical. The energy of activation for the process 3 - 4 is 12.8 kcal mol-1, which is in excellent agreement with theoretical values derived from force-field calculations. Ring-closure of appropriately substituted (4-methylenecyclohexyl)methyl radical precursors allows the synthesis of bicyclo[2.2.1]heptyl systems with useful functionality at the bridgehead to be achieved readily and in high yield. An interesting example is given of the application of an iodine-atom-transfer cyclization to the synthesis of a bicyclo[2.2.1]heptane functionalized at C7 and C1.
    DOI:
    10.1021/jo00060a029
点击查看最新优质反应信息

文献信息

  • Photochemistry of alkyl halides. 4. 1-Norbornyl, 1-norbornylmethyl, 1- and 2-adamantyl, and 1-octyl bromides and iodides
    作者:Paul J. Kropp、Graham S. Poindexter、Norbert J. Pienta、David C. Hamilton
    DOI:10.1021/ja00441a043
    日期:1976.12
    Competing ionic and radical photobehavior has been observed for a number of alkyl halides. The proportion of nucleophilic substitution and reduction products were reported for each halide. Solvent effects of ethylene glycol, triethylamine, and methanol and atmospheric effects of nitrogen, oxygen, and air were studied. The effect of irradiation of the halides with methanol-O-d was reported. The results
    已经观察到许多卤代烷具有竞争性的离子和自由基光行为。报告了每种卤化物的亲核取代和还原产物的比例。研究了乙二醇、三乙胺和甲醇的溶剂效应以及氮气、氧气和空气的大气效应。报告了用甲醇-Od 辐照卤化物的效果。根据碳 - 卤素键的初始均裂以提供自由基对来讨论结果,该自由基对经历竞争性扩散和夺氢以产生还原产物和电子转移以提供离子对。离子对反过来产生取代和消除产物。(DDA)
  • 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
    申请人:Acton, III John J.
    公开号:US11149036B2
    公开(公告)日:2021-10-19
    The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.
    本发明涉及吡唑-4-基吡啶化合物,它们是 M4 肌乙酰胆碱受体的异位调节剂。本发明还涉及本文所述化合物在潜在治疗或预防涉及 M4 肌 肉碱乙酰胆碱受体的神经和精神疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在预防或治疗涉及 M4 蕈样乙酰胆碱受体的此类疾病中的用途。
  • Notes - Synthesis and Rate of Acettolysis of 1-Bicyclo[2.2.1]- heptylmethyl Tosylate
    作者:Robert Bixler、Carl Niemann
    DOI:10.1021/jo01099a600
    日期:1958.5
  • Long-range corner participation by cyclopropane. 3. Synthesis and study of substituted tetracyclononanes and tetracyclodecanes
    作者:Philip J. Chenier、Diane M. Christie、Virginia M. Goettl
    DOI:10.1021/jo00217a041
    日期:1985.8
  • CHENIER P. J.; KILAND P. J.; SCHMITT G. D.; VANDERWEGEN P. G., J. ORG. CHEM., 1980, 45, NO 26, 5413-5417
    作者:CHENIER P. J.、 KILAND P. J.、 SCHMITT G. D.、 VANDERWEGEN P. G.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐